Clinical Trial Update: CD7 CAR-T Combined With Autologous Hematopoietic Stem Cell Transplantation [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial investigating CD7 CAR-T therapy in combination with autologous hematopoietic stem cell transplantation for CD7-positive lymphomas, curr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• T-cell Lymphoma

Drugs mentioned

• Autologous hematopoietic stem cell transplantation (Autologous hematopoietic stem cell transplantation)
• CD7 CAR-T (CD7-directed chimeric antigen receptor T-cell therapy)

Snippet

Sponsor: Zhengzhou University | Conditions: CD7+ Lymphoma, T Cell Lymphoma | Phase 1, Phase 2 | Status: NOT_YET_RECRUITING